Pfizer has resolved a lawsuit by a conservative group that alleged that a fellowship program that the drugmaker established ...

Shares of Pfizer Inc. PFE shed 1.45% to $26.52 Friday, on what proved to be an all-around grim trading session for the stock ...

Pfizer Inc. and a conservative group agreed to end litigation challenging the legality of the company’s multi-year ...

The work underway at the former Pfizer headquarters marks a significant addition to Gensler’s office-to-residential ...

The company's revenue from operations dipped 0.4% to ₹538 crore as against ₹540 crore in the corresponding period of the preceding fiscal. At the operating level, EBITDA fell ...

Dividend stocks have remained a focal point for investors, especially amid market volatility and the growing need for steady ...

The former President of Pfizer Global Manufacturing gifted $50 million to his former school, Northfield Mount Hermon.

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $32.00. The ...

With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...

The contrarian in me says that when everybody’s bullish about everything, it’s time to get a little cautious,’ says John ...

Drugmakers have raised the list prices of more than 800 prescription drugs — ranging from blood pressure medications to cancer treatments — by a median of 4% at the start of this year, The Wall Street ...

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...